Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: DiaMedica Therapeutics Inc., 3 years.
DiaMedica Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
DiaMedica Therapeutics Inc. May 20, 202698.0%
-
DiaMedica Therapeutics Inc. May 15, 202595.8%
-
DiaMedica Therapeutics Inc. May 22, 202497.5%
-
DiaMedica Therapeutics Inc. May 17, 202393.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 13, 2023 | Replimune Group Inc. | Open-market sale | −12,043 | $24.10 | $290,236 |
| Jun 13, 2023 | Replimune Group Inc. | Open-market sale | −817 | $23.45 | $19,159 |
| May 16, 2023 | Replimune Group Inc. | Open-market sale | −12,207 | $18.05 | $220,336 |
| Apr 1, 2023 | Replimune Group Inc. | Grant or award | +40,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.